{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:57:10Z","timestamp":1753891030994,"version":"3.41.2"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Inflammatory rheumatic diseases (IRD) and autoimmune liver diseases (AILD) share many similarities regarding epidemiology, genetics, immunology and therapeutic regimens, so it is not surprising that approximately 20% of patients with AILD are diagnosed with an IRD as well. Clinical features and biochemical hallmarks of IRD and AILD often intertwine and cross diagnostic criteria. Therefore, the real distinction of underlying disorders in a patient with these comorbidities may be challenging. The present report is the first report of simultaneously developed juvenile dermatomyositis (JDM) and autoimmune sclerosing cholangitis (ASC) with both entities fulfilling the latest guidelines for a definite diagnosis. Both of these diagnoses are difficult to definitely establish since ASC has a similar serologic profile as autoimmune hepatitis and liver histological analysis is frequently non-specific, whereas clinically amyopathic JDM diagnosis depends mostly on classical dermatological symptoms, while the rest of the diagnostic criteria, including the necessity for skin or muscle biopsy and the presence of myositis specific antibodies, are still not uniformed. In spite of these challenges, our patient clearly met European League Against Rheumatism\/American College of Rheumatology classification criteria for CAJDM and The European Society for Pediatric Gastroenterology, Hepatology and Nutrition diagnostic criteria for ASC. Since elevated serum transaminases, the presence of serum antinuclear antibodies and hypergammaglobulinemia could be explained as a part of both JDM and ASC, the underlying pathophysiology remains debatable. Intriguingly, JDM and ASC share genetic predisposition including human leukocyte antigen allele DRB1*0301 and tumor necrosis factor \u03b1 308A allele. Furthermore, both humoral and cellular components of the adaptive immune system contribute to the pathogenesis of JDM and ASC. Moreover, recent findings indicate that the loss of the CD28 expression on T-cells plays a significant role in their pathogenesis along with the Th17 immune pathway. Despite these common features that suggest shared autoimmunity, AILD and autoimmune myositis are traditionally studied and managed independently. The lack of therapies that target the underlying cause results in a high rate of adverse events due to unspecific immunosuppressive therapy. Shared autoimmunity is an ideal area to develop new, targeted immunotherapy that would hopefully be beneficial for more than one disease.<\/jats:p>","DOI":"10.3389\/fimmu.2022.825799","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T09:21:24Z","timestamp":1645608084000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Simultaneously Developed Amyopathic Dermatomyositis and Autoimmune Sclerosing Cholangitis \u2013 a Coincidence or a Shared Immunopathogenesis?"],"prefix":"10.3389","volume":"13","author":[{"given":"Tomislav","family":"Ledenko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iva","family":"Sori\u0107 Hosman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marijana","family":"\u0106ori\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alenka","family":"Gagro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/rheumatology\/keu289","article-title":"Incidence and Prevalence of Inflammatory Myopathies: A Systematic Review","volume":"54","author":"Meyer","year":"2015","journal-title":"Rheumatology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups [Published Correction Appears in Ann Rheum Dis. 2018 Sep;77(9):E64]","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1001\/archdermatol.2009.328","article-title":"Incidence of Dermatomyositis and Clinically Amyopathic Dermatomyositis: A Population-Based Study in Olmsted County, Minnesota","volume":"146","author":"Bendewald","year":"2010","journal-title":"Arch Dermatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13013","article-title":"How Often are Pediatric Patients With Clinically Amyopathic Dermatomyositis Truly Amyopathic","volume":"34","author":"Oberle","year":"2017","journal-title":"Pediatr Dermatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26454","article-title":"Primary Sclerosing Cholangitis, Autoimmune Hepatitis, and Overlap in Utah Children: Epidemiology and Natural History","volume":"58","author":"Deneau","year":"2013","journal-title":"Hepatology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000001801","article-title":"Diagnosis and Management of Pediatric Autoimmune Liver Disease: ESPGHAN Hepatology Committee Position Statement","volume":"66","author":"Mieli-Vergani","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000038","article-title":"Serum Transaminases are Frequently Elevated at Time of Diagnosis of Idiopathic Inflammatory Myopathy and Normalize With Creatine Kinase","volume":"20","author":"Mathur","year":"2014","journal-title":"J Clin Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18096","article-title":"Skin Myositis Delphi Group. Developing Classification Criteria for Skin-Predominant Dermatomyositis: The Delphi Process","volume":"182","author":"Concha","year":"2020","journal-title":"Br J Dermatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2020.1718866","article-title":"Clinical Practice Guidance for Juvenile Dermatomyositis (JDM) 2018-Update","volume":"30","author":"Kobayashi","year":"2020","journal-title":"Mod Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-016-0134-0","article-title":"Childhood Arthritis and Rheumatology Research Alliance Consensus Clinical Treatment Plans for Juvenile Dermatomyositis With Skin Predominant Disease","volume":"15","author":"Kim","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209247","article-title":"Consensus-Based Recommendations for the Management of Juvenile Dermatomyositis","volume":"76","author":"Bellutti Enders","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.12.074","article-title":"Dermatomyositis: A Diagnostic Dilemma","volume":"79","author":"Da Silva","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jaad.2017.12.055","article-title":"Applicability of EULAR\/ACR Classification Criteria for Dermatomyositis to Amyopathic Disease","volume":"79","author":"Patel","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"15e24","DOI":"10.29021\/spdv.77.1.1021","article-title":"The Importance of New Specific Autoantibodies in Dermatomyositis","volume":"77","author":"Calvao","year":"2019","journal-title":"Rev Soc Port Dermatol Venereol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08055.x","article-title":"A Systematic Review of Juvenile-Onset Clinically Amyopathic Dermatomyositis","volume":"157","author":"Gerami","year":"2007","journal-title":"Br J Dermatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1542\/peds.100.3.391","article-title":"Juvenile Dermatomyositis Presenting With Rash Alone","volume":"100","author":"Eisenstein","year":"1997","journal-title":"Pediatrics"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120620","article-title":"Amyopathic Dermatomyositis: Retrospective Review of 37 Cases","volume":"46","author":"El-Azhary","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaad.2005.10.041","article-title":"A Systematic Review of Adult Onset Clinically-Amyopathic Dermatomyositis (Syn. Dermatomyositis Sine Myositis): A Missing Link Within the Spectrum of the Idiopathic Inflammatory Myopathies","volume":"54","author":"Gerami","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel009","article-title":"Serum Alanine Aminotransferase Elevations Correlate With Serum Creatine Phosphokinase Levels in Myositis","volume":"45","author":"Edge","year":"2006","journal-title":"Rheumatol (Oxford)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0676.2000.020005366.x","article-title":"The Liver in Collagen Diseases: Pathologic Study of 160 Cases With Particular Reference to Hepatic Arteritis, Primary Biliary Cirrhosis, Autoimmune Hepatitis and Nodular Regenerative Hyperplasia of the Liver","volume":"20","author":"Matsumoto","year":"2000","journal-title":"Liver"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-010-0397-0","article-title":"Polymyositis Associated With Autoimmunehepatitis, Primary Biliary Cirrhosis, and Autoimmune Thrombocytopenic Purpura","volume":"21","author":"Kurihara","year":"2011","journal-title":"Mod Rheumatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.59.5.558","article-title":"Autoimmune Chronic Active Hepatitis and Polymyositis in a Patient With Myasthenia Gravis and Thymoma","volume":"59","author":"Ko","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.5414\/CNP70245","article-title":"A Case of Membranous Nephropathy Associated With Sj\u00f6gren Syndrome, Polymyositis and Autoimmune Hepatitis","volume":"70","author":"Stefanidis","year":"2008","journal-title":"Clin Nephrol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2005.01321.x","article-title":"Systemic Sclerosis-Polymyositis Overlap Syndrome Accompanied by Autoimmune Hepatitis and Sarcoidosis of Mediastinal Lymphnodes","volume":"20","author":"Lis-Swiety","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/ard.59.10.839a","article-title":"Polymyositis, Cranial Neuropathy, Autoimmune Hepatitis, and Hepatitis C","volume":"59","author":"Marie","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bcr.09.2011.4763","article-title":"Simultaneously Developed Polymyositis and Autoimmune Hepatitis","volume":"2011","author":"Hounoki","year":"2011","journal-title":"BMJ Case Rep"},{"key":"B27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.5152\/eurjrheum.2018.17135","article-title":"Inflammatory Myopathy and Autoimmune Hepatitis in a Patient With a Flare of Systemic Lupus Erythematosus: An Exceptional Association","volume":"5","author":"Salman-Monte","year":"2018","journal-title":"Eur J Rheumatol"},{"key":"B28","article-title":"Hepatite Autoimune E Dermatomiosite: Uma Rara Associa\u00e7\u00e3o [Autoimmune Hepatitis and Dermatomyositis: A Rare Association]","volume":"37","author":"De Souza","year":"2012","journal-title":"Acta Reumatol Port"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.15403\/jgld.2014.1121.cpa","article-title":"Primary Biliary Cirrhosis\u2013Autoimmune Hepatitis Overlap Syndrome Associated With Dermatomyositis, Autoimmune Thyroiditis and Antiphospholipid Syndrome","volume":"24","author":"Pamfil","year":"2015","journal-title":"J Gastrointest Liver Dis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune Hepatitis\/Sclerosing Cholangitis Overlap Syndrome in Childhood: A 16-Year Prospective Study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cld.2015.08.008","article-title":"Sclerosing Cholangitis in Children and Adolescents","volume":"20","author":"Mieli-Vergani","year":"2016","journal-title":"Clin Liver Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: Review of Criteria for Diagnosis of Autoimmune Hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.10.007","article-title":"Serum Antinuclear and Extractable Nuclear Antigen Antibody Prevalence and Associated Morbidity and Mortality in the General Population Over 15 Years","volume":"15","author":"Selmi","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/joim.12444","article-title":"The Juvenile Idiopathic Inflammatory Myopathies: Pathogenesis, Clinical and Autoantibody Phenotypes, and Outcomes","volume":"280","author":"Rider","year":"2016","journal-title":"J Intern Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jaut.2017.06.007","article-title":"Autoantibodies in Juvenile-Onset Myositis: Their Diagnostic Value and Associated Clinical Phenotype in a Large UK Cohort","volume":"84","author":"Tansley","year":"2017","journal-title":"J Autoimmun"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key190","article-title":"Childhood Myositis Heterogeneity Collaborative Study Group. Features Distinguishing Clinically Amyopathic Juvenile Dermatomyositis From Juvenile Dermatomyositis","volume":"57","author":"Mamyrova","year":"2018","journal-title":"Rheumatol (Oxford)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/MD.0b013e31816bc604","article-title":"Predictors of Acquired Lipodystrophy in Juvenile-Onset Dermatomyositis and a Gradient of Severity","volume":"87","author":"Bingham","year":"2008","journal-title":"Med (Baltimore)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e31829d08f9","article-title":"The Myositis Autoantibody Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies","volume":"92","author":"Rider","year":"2013","journal-title":"Med (Baltimore)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem359","article-title":"Clinical Associations of Autoantibodies to a P155\/140 kDa Doublet Protein in Juvenile Dermatomyositis","volume":"47","author":"Gunawardena","year":"2008","journal-title":"Rheumatol (Oxford)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/art.39753","article-title":"UK Juvenile Dermatomyositis Research Group Muscle Biopsy Findings in Combination With Myositis-Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis","volume":"68","author":"Deakin","year":"2016","journal-title":"Arthritis Rheum"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3091","article-title":"Use of Anti-Transcriptional Intermediary Factor-1 Gamma Autoantibody in Identifying Adult Dermatomyositis Patients With Cancer: A Systematic Review and Meta-Analysis","volume":"99","author":"Best","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-311739","article-title":"Anti-GP2 IgA Autoantibodies are Associated With Poor Survival and Cholangiocarcinoma in Primary Sclerosing Cholangitis","volume":"66","author":"Jendrek","year":"2017","journal-title":"Gut"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14791","article-title":"Anti-Gp210 and Other Anti-Nuclear Pore Complex Autoantibodies in Primary Biliary Cholangitis: What We Know and What We Should Know","volume":"41","author":"Cristoferi","year":"2021","journal-title":"Liver Int"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2012.07.008","article-title":"Antineutrophil Cytoplasmic Auto-Antibodies (ANCA) in Autoimmune Hepatitis and Primary Sclerosing Cholangitis, Clin","volume":"37","author":"Deniziaut","year":"2013","journal-title":"Res Hepatol Gastroenterol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840170310","article-title":"Prevalence and Characterization of Neutrophil Cytoplasmic Antibodies in Autoimmune Liver Diseases","volume":"17","author":"Mulder","year":"1993","journal-title":"Hepatology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/iub.1349","article-title":"Regulatory T Cells: Mechanisms of Suppression and Impairment in Autoimmune Liver Disease","volume":"67","author":"Liberal","year":"2015","journal-title":"IUBMB Life"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29307","article-title":"Regulatory T-Cell Conditioning Endows Activated Effector T Cells With Suppressor Function in Autoimmune Hepatitis\/Autoimmune Sclerosing Cholangitis","volume":"66","author":"Liberal","year":"2017","journal-title":"Hepatology"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/art.24936","article-title":"Interleukin-6 and Type I Interferon-Regulated Genes and Chemokines Mark Disease Activity in Dermatomyositis","volume":"60","author":"Bilgic","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e29161","DOI":"10.1371\/journal.pone.0029161","article-title":"Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogenecity Across Diseases","volume":"7","author":"Wong","year":"2012","journal-title":"PloS One"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160293","article-title":"Gene Expression Profiling in Blood and Affected Muscle Tissues Reveals Differential Activation Pathways in Patients With New-Onset Juvenile and Adult Dermatomyositis","volume":"44","author":"L\u00f3pez De Padilla","year":"2017","journal-title":"J Rheumatol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-015-2662-x","article-title":"Human Leucocyte Antigens and Pediatric Autoimmune Liver Disease: Diagnosis and Prognosis","volume":"175","author":"Junge","year":"2016","journal-title":"Eur J Pediatr"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000000245","article-title":"Autoantibody and Human Leukocyte Antigen Profiles in Children With Autoimmune Liver Disease and Their First-Degree Relatives","volume":"58","author":"Wang","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/art.22205","article-title":"HLA Polymorphisms in African Americans With Idiopathic Inflammatory Myopathy: Allelic Profiles Distinguish Patients With Different Clinical Phenotypes and Myositis Autoantibodies","volume":"54","author":"O\u2019Hanlon","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B54","article-title":"Modification of Cytokine Patterns in Subjects Bearing the HLA-B8,DR3 Phenotype: Implications for Autoimmunity","volume":"3","author":"Lio","year":"1997","journal-title":"Cytokines Cell Mol Ther"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1006\/clim.2001.5063","article-title":"Expression of TNFalpha by Muscle Fibers in Biopsies From Children With Untreated Juvenile Dermatomyositis: Association With the TNFalpha-308A Allele","volume":"100","author":"Fedczyna","year":"2001","journal-title":"Clin Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-018-9867-4","article-title":"Association of TNF-\u03b1-308 Polymorphism With Susceptibility to Autoimmune Hepatitis in Tunisians","volume":"56","author":"Chaouali","year":"2018","journal-title":"Biochem Genet"},{"key":"B57","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1053\/j.gastro.2014.04.003","article-title":"Loss of CD28 Expression by Liver-Infiltrating T Cells Contributes to Pathogenesis of Primary Sclerosing Cholangitis","volume":"147","author":"Liaskou","year":"2014","journal-title":"Gastroenterology"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9440(10)65141-3","article-title":"Expression of the Costimulatory Molecule BB-1, the Ligands CTLA-4 and CD28, and Their mRNA in Inflammatory Myopathies","volume":"155","author":"Murata","year":"1999","journal-title":"Am J Pathol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/art.21068","article-title":"History of Infection Before the Onset of Juvenile Dermatomyositis:Results From the National Institute of Arthritis and Musculoskeletaland Skin Diseases Research Registry","volume":"53","author":"Pachman","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B60","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12016-008-8088-8","article-title":"Atypical P-ANCA in PSC and AIH: A Hint Toward a \u201cLeaky Gut\u201d","volume":"36","author":"Terjung","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.6.2237","article-title":"Autoantibodies From Patients With Primary Biliary Cirrhosis Recognize a Restricted Region Within the Cytoplasmic Tail of Nuclear Pore Membrane Glycoprotein Gp210","volume":"178","author":"Nickowitz","year":"1993","journal-title":"J Exp Med"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken074","article-title":"Effectiveness of Infliximab in the Treatment of Refractory Juvenile Dermatomyositis With Calcinosis","volume":"47","author":"Riley","year":"2008","journal-title":"Rheumatol (Oxford)"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.11.010","article-title":"Infliximab as a Rescue Treatment in Difficult-to-Treat Autoimmune Hepatitis","volume":"58","author":"Weiler-Normann","year":"2013","journal-title":"J Hepatol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.05.046","article-title":"Infliximab as Rescue Therapy in Paediatric Autoimmune Hepatitis","volume":"59","author":"Rajanayagam","year":"2013","journal-title":"J Hepatol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i24.7584","article-title":"Autoimmune Hepatitis and Anti-Tumor Necrosis Factor Alpha Therapy: A Single Center Report of 8 Cases","volume":"21","author":"Rodrigues","year":"2015","journal-title":"World J Gastroenterol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000001137","article-title":"Infliximab-Associated Immunomediated Hepatitis in Children With Inflammatory Bowel Disease","volume":"63","author":"Mostamand","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2011.49","article-title":"Double Trouble: Therapeutic Challenges in Patients With Both Juvenile Dermatomyositis and Psoriasis","volume":"147","author":"Kim","year":"2011","journal-title":"Arch Dermatol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.02.029","article-title":"Use of Tnf\u03b1 Antagonists in Refractory AIH: Revealing the Unforeseen","volume":"59","author":"Saitis","year":"2013","journal-title":"J Hepatol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e318291feaa","article-title":"Sirolimus as Rescue Therapy in Pediatric Autoimmune Hepatitis","volume":"58","author":"Kurowski","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.825799\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T09:21:31Z","timestamp":1645608091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.825799\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,23]]},"references-count":69,"alternative-id":["10.3389\/fimmu.2022.825799"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.825799","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2022,2,23]]},"article-number":"825799"}}